The p53 tumor suppressor protein, is a key cellular regulatory component, that participate in controlling cell growth and death. As an essential determinant in p53's ability to mediate its multiple functions lies in its stability, we are studying the mechanisms that regulate p53 stability. We propose to test the hypothesis that the interplay between mdm2 and TAFs is an important regulator of p53 stability Being part of the transcription initiation complex, TAF displacement of mdm2 is expected to confer transcriptional activity of p53. It has been shown that the p53 interacting protein, mdm2, destabilizes p53 and our preliminary results indicate that mdm2 targets p53 ubiquitination. P53 stability is also affected by another interacting molecule, JNK (Jun-N-terminal kinase), that targets the ubiquitination and degradation of p53 in an mdm2-independent manner. The hypothesis that p53 stability is determined by a delicate balance between mdm2 and TAFs is supported by the finding that over-expression of the p53 co-activator, TAFII31 stabilizes p53 in mammalian cells. TO test our hypothesis we propose to: 1) evaluate the interplay between TAFII31 and mdm2 towards p53 stability using our novel in ubiquitination and in vitro degradation systems; 2) use an in vivo ubiquitination system to monitor the contribution of mdm2/TAFII31 to p53 stability in cells derived from the ubiquitination system to monitor the contribution of mdm2/TAFII31 to p53 stability is cells derived from p53+/+, p53-/-, p53/mdm2-/- knockout mice under non-stressed and DNA damaging conditions; and 3) identify the domains of mdm2 and TAFs that mediate regulation of p53 stability and subsequently identify mdm2 and TAFs-derived peptides that could alter p53 stability in vitro and subsequently in vivo. In our fourth aim, we plan to explore the possible involvement of deregulated TAFII31 in tumorigenesis. Tumor cells with varying levels of TAF expression would provide a relevant physiologic resource to study the effect of mdm2-TAFs imbalance on p53 stability and function. Because p53 stability is control to its regulatory activities, understanding the mechanism underlying its stability will be necessary to decipher its action as a tumor suppressor.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
5P01CA080058-02
Application #
6416244
Study Section
Subcommittee G - Education (NCI)
Project Start
2001-02-01
Project End
2002-01-31
Budget Start
Budget End
Support Year
2
Fiscal Year
2001
Total Cost
$237,979
Indirect Cost
Name
Mount Sinai School of Medicine
Department
Type
DUNS #
City
New York
State
NY
Country
United States
Zip Code
10029
Pappas, Kyrie; Xu, Jia; Zairis, Sakellarios et al. (2017) p53 Maintains Baseline Expression of Multiple Tumor Suppressor Genes. Mol Cancer Res 15:1051-1062
Mungamuri, Sathish Kumar; Qiao, Rui F; Yao, Shen et al. (2016) USP7 Enforces Heterochromatinization of p53 Target Promoters by Protecting SUV39H1 from MDM2-Mediated Degradation. Cell Rep 14:2528-37
Muñoz-Fontela, César; Mandinova, Anna; Aaronson, Stuart A et al. (2016) Emerging roles of p53 and other tumour-suppressor genes in immune regulation. Nat Rev Immunol 16:741-750
Ou, Yang; Wang, Shang-Jui; Li, Dawei et al. (2016) Activation of SAT1 engages polyamine metabolism with p53-mediated ferroptotic responses. Proc Natl Acad Sci U S A 113:E6806-E6812
Guernet, Alexis; Mungamuri, Sathish Kumar; Cartier, Dorthe et al. (2016) CRISPR-Barcoding for Intratumor Genetic Heterogeneity Modeling and Functional Analysis of Oncogenic Driver Mutations. Mol Cell 63:526-38
Meslamani, Jamel; Smith, Steven G; Sanchez, Roberto et al. (2016) Structural features and inhibitors of bromodomains. Drug Discov Today Technol 19:3-15
Hwang, So-Young; Deng, Xianming; Byun, Sanguine et al. (2016) Direct Targeting of ?-Catenin by a Small Molecule Stimulates Proteasomal Degradation and Suppresses Oncogenic Wnt/?-Catenin Signaling. Cell Rep 16:28-36
Shi, D; Dai, C; Qin, J et al. (2016) Negative regulation of the p300-p53 interplay by DDX24. Oncogene 35:528-36
Tavana, Omid; Li, Dawei; Dai, Chao et al. (2016) HAUSP deubiquitinates and stabilizes N-Myc in neuroblastoma. Nat Med 22:1180-1186
Wang, Donglai; Kon, Ning; Lasso, Gorka et al. (2016) Acetylation-regulated interaction between p53 and SET reveals a widespread regulatory mode. Nature 538:118-122

Showing the most recent 10 out of 101 publications